
GordonMD Global Investments
Beverly Hills, California, United StatesFounded 2021
GordonMD Global Investments is a Beverly Hills-based alternative investment firm founded in 2021 by Craig Gordon, MD, focused exclusively on global biopharmaceutical and life sciences companies. The firm manages both private and public funds, targeting differentiated investment opportunities across private and publicly traded growth-stage companies.
47% of their portfolio is in Biotech & Life Sciences. They made 4 investments in the last 12 months. Average disclosed round size is $85.1M (across 14 rounds with reported amounts).
Portfolio
15
Fund Size
$322.3M
Top Stage
Series A
Last 12 Mo
4
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series C | — | Jul 2026 | |
| Series A | $20M | Jun 2026 | |
| Series A | $100M | Apr 2026 | |
| SStipple | Series A | $100M | Apr 2026 |
| Series D | $125M | Jan 2025 | |
| SStar Tx | Series D | $125M | Jan 2025 |
| Series A | $52.5M | Jan 2024 | |
| KKyverna Therapeutics | Series B | $60M | Aug 2023 |
| Series B | $123M | Mar 2023 | |
| SSalioGen Therapeutics | Series B | $115M | Jan 2022 |
| Series B | $115M | Jan 2022 | |
| SStipple | Series A | $5M | May 2012 |
| Series C | $200M | — | |
| Series C | — | — | |
| AAmlogenyx | Seed | $14M | — |
| SSpotlight Therapeutics | Series B | $36.5M | — |
| Series A | — | — |
Top Co-Investors
Nextech Invest Ltd.4 shared
Emerson Collective4 shared
EPIQ Capital Group4 shared
Frazier Life Sciences3 shared
D1 Capital Partners3 shared
T. Rowe Price3 shared
RD Fund3 shared
Cystic Fibrosis Foundation3 shared
SymBiosis3 shared
GV2 shared
RA Capital Management2 shared
Sanofi Ventures2 shared
Westlake Village BioPartners2 shared
Cormorant Asset Management2 shared
Agent Capital2 shared
Viking Global Investors2 shared
Andera Partners2 shared
M Ventures2 shared
Kleiner Perkins2 shared
Last updated: 20 October 2026